The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
Clinical trial NCT02267525 · COMPLETED
Trial details
- NCT number
- NCT02267525
- Sponsor
- Theravance Biopharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-06-01
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.